Search Results - (Author, Cooperation:C. Feruglio)
-
1Latest Papers from Table of Contents or Articles in PressH. Fu ; A. Cooray ; C. Feruglio ; R. J. Ivison ; D. A. Riechers ; M. Gurwell ; R. S. Bussmann ; A. I. Harris ; B. Altieri ; H. Aussel ; A. J. Baker ; J. Bock ; M. Boylan-Kolchin ; C. Bridge ; J. A. Calanog ; C. M. Casey ; A. Cava ; S. C. Chapman ; D. L. Clements ; A. Conley ; P. Cox ; D. Farrah ; D. Frayer ; R. Hopwood ; J. Jia ; G. Magdis ; G. Marsden ; P. Martinez-Navajas ; M. Negrello ; R. Neri ; S. J. Oliver ; A. Omont ; M. J. Page ; I. Perez-Fournon ; B. Schulz ; D. Scott ; A. Smith ; M. Vaccari ; I. Valtchanov ; J. D. Vieira ; M. Viero ; L. Wang ; J. L. Wardlow ; M. Zemcov
Nature Publishing Group (NPG)
Published 2013Staff ViewPublication Date: 2013-05-24Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsPublished by: -
2Articles: DFG German National LicensesStaff View
ISSN: 0003-9861Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002Topics: BiologyChemistry and PharmacologyPhysicsType of Medium: Electronic ResourceURL: -
3Articles: DFG German National LicensesSemenzato, G. ; Bambara, L. M. ; Biasi, D. ; Frigo, A. ; Vinante, F. ; Zuppini, B. ; Trentin, L. ; Feruglio, C. ; Chilosi, M. ; Pizzolo, G.
Springer
Published 1988Staff ViewISSN: 1573-2592Keywords: Soluble interleukin-2 receptor ; systemic lupus erythematosus ; rheumatoid arthritisSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract In this study we investigated the serum levels of a released soluble form of the interleukin-2 receptor (sIL-2R) in 42 patients with rheumatoid arthritis and in 12 cases of systemic lupus erythematosus. Data were evaluated in relationship to the clinical phase and compared with those observed in normal controls (N=56) and in osteoarthritis (N = 7). Increased levels were observed in both rheumatoid arthritis (mean ± SE, 604±49 U/ml) and systemic lupus erythematosus (1438±481 U/ml). These values were significantly higher than in control (256±15 U/ml;P〈0.001) and in osteoarthritis (298±33 U/ml;P〈0.001) groups. In addition, the highest values were associated with the active phases of both rheumatoid arthritis (active vs inactive, 771±78 vs 451±39 U/ml;P〈0.001) and systemic lupus erythematosus (active vs inactive, 2108±489 vs 499±75 U/ml;P〈0.001). Our findings suggest that the detection of sIL-2R in rheumatoid arthritis and in systemic lupus erythematosus may represent a good marker of disease activity, which indirectly indicates the ongoing activation and/or proliferation of immunoreactive cells which are involved in the pathogenetic events of these autoimmune conditions.Type of Medium: Electronic ResourceURL: